Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
178.7 INR | +6.12% | +1.60% | +4.53% |
06-28 | Dishman Carbogen Amcis Receives FDA Clearance for Swiss Manufacturing Facilities | MT |
05-31 | Transcript : Dishman Carbogen Amcis Limited, Q4 2024 Earnings Call, May 31, 2024 |
Business Summary
Number of employees: 1,295
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Contract Research and Manufacturing Services
80.6
%
| 16,493 | 77.0 % | 19,453 | 80.6 % | +17.95% |
Marketable Molecules (including Others)
19.4
%
| 4,914 | 23.0 % | 4,676 | 19.4 % | -4.83% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 367 | 1.7 % | 24,129 | 100.0 % | +6,483.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 38 | 06/04/12 | |
Harshil R. Dalal
DFI | Director of Finance/CFO | 42 | - |
Paolo Armanino
COO | Chief Operating Officer | - | - |
Compliance Officer | 37 | 16/03/17 | |
Dharmesh Desai
LAW | General Counsel | - | - |
Martin Schneider
PRN | Corporate Officer/Principal | - | - |
Stephan Fritschi
PRN | Corporate Officer/Principal | 63 | - |
Dieter Thueer
HRO | Human Resources Officer | - | - |
Alan Fischer
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 16/03/07 | |
Director/Board Member | 73 | 16/03/17 | |
Director/Board Member | 76 | 16/03/17 | |
Chief Executive Officer | 38 | 06/04/12 | |
Subir Kumar Das
BRD | Director/Board Member | 70 | 16/03/17 |
Director/Board Member | 42 | 31/03/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 156,783,095 | 46,125,444 ( 29.42 %) | 0 | 29.42 % |
Company contact information
Dishman Carbogen Amcis Ltd.
Dishman Corporate House Opp. Jayantilal Park BRTS
380058, Ahmedabad
+91 27 1742 0102
http://imdcal.comGroup companies
Name | Category and Sector |
---|---|
Dishman Europe Ltd.
Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Europe Ltd. is a British company that imports and markets a wide range of chemical products and pharmaceutical ingredients. The company is based in London, UK. Dishman Europe was founded in 1997. |
Pharmaceuticals: Major
|
Dishman Netherlands BV
Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients. |
Pharmaceuticals: Other
|
Sector
Sales per Business
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.53% | 336M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- DCAL Stock
- Company Dishman Carbogen Amcis Limited